News | Enterprise Imaging | February 06, 2019

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

Next-generation enterprise-wide health informatics platform now includes IntelliSpace Precision Medicine Oncology, IntelliSpace Genomics and interoperable clinical data sharing with IntelliSpace Exchange

Philips Spotlights IntelliSpace Enterprise Edition at HIMSS 2019

February 6, 2019 — Philips announced it has expanded its IntelliSpace Enterprise Edition, which combines Philips Radiology, Cardiology portfolios and PerformanceBridge, to now include the new IntelliSpace Precision Medicine Oncology, IntelliSpace Precision Medicine Genomics and IntelliSpace Exchange solutions.

Being showcased at the Healthcare Information Management Systems Society (HIMSS) 2019 annual event, Feb. 11-15 in Orlando, Fla., the enhanced integration builds on the existing suite of offerings from IntelliSpace Enterprise Edition to provide an enterprise-wide health informatics solution. With this latest expansion, health systems now have access to advanced technology solutions to help reduce costs, improve patient and staff satisfaction, and transform towards value-based care.

Precision medicine has great potential for individualized diagnoses and treatment for cancer patients. However, due to the increasing number of complex data sources needed to leverage it effectively, clinicians need tools to help them seamlessly aggregate all key data to provide a clear, intuitive view of a patient’s condition. With the latest additions to the solution, IntelliSpace Enterprise Edition is designed to enable the seamless flow of data, information enterprise management and improved care, combining radiology, cardiology and growing towards precision medicine.

CarolinaEast, an award-winning health system for patient experience and cardiac care based in New Bern, N.C., was one of the first to collaborate with Philips to implement IntelliSpace Enterprise Edition, which began with the Philips Radiology and Cardiology portfolios. Having first implemented the solution in the fall of 2018, early results show improvements in workflow, communication and operational efficiencies.

“CarolinaEast has been working with Philips for many years, and the company has always proven to be a valuable partner. With the introduction of IntelliSpace Enterprise Edition, Philips has further demonstrated its commitment to our success by providing insight into best practices and the tools to help us achieve our critical goals,” said Mike Ciancio, imaging systems administrator, CarolinaEast Health System. “Philips has helped us identify areas for improvement so we can streamline and standardize our processes to help deliver more efficient and seamlessly integrated care.”

Philips IntelliSpace Enterprise Edition brings the managed services business model to more clinical solutions, for enterprise-wide informatics across care settings. New features include:

  • IntelliSpace Precision Medicine Oncology – features workflow solutions from analysis to treatment decision to enable healthcare organizations to effectively launch, implement and scale precision medicine programs.
  • IntelliSpace Precision Medicine Genomics – seamless workflow platform brings together genomic data alongside disease histology and patient phenotype for a comprehensive biomarker-informed diagnostic and therapeutic picture.
  • IntelliSpace Exchange – provides hospital networks the possibility to easily and seamlessly exchange clinical information, to help improve the overall experience and efficiency through standards-based interoperability.

The IntelliSpace Enterprise Edition informatics suite leverages adaptive intelligence and advanced technology, powered by Philips HealthSuite, to enable health systems to make informed and timely decisions, in the right place at the right time. Beginning in 2019, IntelliSpace Enterprise Edition will continue to expand with additional solutions across new clinical domains, and will become available to more markets internationally.

For more information: www.usa.philips.com/healthcare

Related Content

The impact of deploying artificial intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients.

Getty Images

News | Artificial Intelligence | June 15, 2021
June 15, 2021 — The impact of deploying ...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
International medical imaging IT and cybersecurity company Sectra will install its solution for digital pathology at Institut Curie, one of the most recognized and prestigious cancer centers in France.
News | Enterprise Imaging | May 24, 2021
May 24, 2021 — International medical imaging IT and cybersecurity company ...
The Healthcare Information and Management Systems Society, Inc. (HIMSS) 2021 Conference, scheduled for August 9-13 in Las Vegas, will be one of the first to take a step back to normalcy

Getty Images

News | HIMSS | May 17, 2021
May 17, 2021 — It looks like in-person conferences are making a comeback.
Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Feature | Imaging Technology News - ITN | May 17, 2021 | By Melinda Taschetta-Millane
Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address

Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address inherent biases in healthcare algorithms and their deployment. Image courtesy of Regenstrief Institute

News | Artificial Intelligence | May 14, 2021
May 14, 2021 — Artificial intelligence